IP Library Granted Patent US 8,591,577
Granted Patent B2
US 8,591,577 · App. 12/969,663 · Granted Nov 26, 2013

Capsulotomy device and method using electromagnetic induction heating

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,591,577
App. No.
12/969,663
Granted
Nov 26, 2013
Kind
B2
Abstract

A capsulotomy device for use in an eye having a capsular bag, comprising a conductive, primary coil capable of generating magnetic field lines and a conductive, secondary coil configured to permit insertion through an incision having a diameter of 3 mm or less, and placement on the capsular bag. When the magnetic field lines are projected through the secondary coil, a current is generated within the secondary coil.

Claims (11)

1. A capsulotomy device for use in an eye having a capsular bag, comprising:

a conductive, primary coil capable of generating magnetic field lines; and

a conductive, secondary coil configured to permit insertion through an incision having a diameter of 3 mm or less, and placement on the capsular bag, the primary coil and secondary coil configured to be independently positionable of one another, relative to the eye,

the secondary coil adapted to produce resistive heating sufficient to cause a partial or complete burn trace on the capsular bag in response to the magnetic field lines being projected through the secondary coil.

2. The device of claim 1 , wherein the secondary coil comprises a closed loop.

3. The device of claim 1 , wherein the secondary coil has a magnetic permeability that is greater than the magnetic permeability of water.

4. The device of claim 1 , wherein the secondary coil is configured to form a circular burn trace.

5. The device of claim 1 , wherein the secondary coil comprises at least one of nitinol, stainless steel and plastic.

6. The device of claim 1 , wherein secondary coil is coupled to a handle.

7. The device of claim 1 , wherein the secondary coil is disposed in a syringe-type injector.

8. The device of claim 1 , wherein the primary coil constitutes one of a plurality of coils each configured to generate the magnetic field lines.

Assignments (1)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →